Free Trial
Kevin Grundy

Kevin Grundy Analyst Performance

Managing Director at BNP Paribas Exane

Kevin Grundy is a stock analyst at BNP Paribas Exane focused in the consumer staples sector, covering 18 publicly traded companies. Over the past year, Kevin Grundy has issued 4 stock ratings, including buy, hold, and sell recommendations. While full access to Kevin Grundy's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kevin Grundy's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
147 Last 11 Years
Buy Recommendations
67.81% 99 Buy Ratings
Companies Covered
18 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy1.4%2 ratings
Buy66.4%97 ratings
Hold26.0%38 ratings
Sell6.2%9 ratings

Out of 146 total stock ratings issued by Kevin Grundy at BNP Paribas Exane, the majority (66.4%) have been Buy recommendations, followed by 26.0% Hold, 6.2% Sell, and 1.4% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NYSE
66.7% of companies on NYSE
12 companies
NASDAQ
33.3% of companies on NASDAQ
6 companies

Kevin Grundy, an analyst at BNP Paribas Exane, currently covers 18 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Consumer Staples
16 companies
88.9%
Consumer Discretionary
1 company
5.6%
Medical
1 company
5.6%

Kevin Grundy of BNP Paribas Exane specializes in stock coverage within the Consumer Staples sector, with additional focus on Consumer Discretionary and Medical companies.

Coverage Industries

IndustryPercentage
CONS PD - MISC STPL
6 companies
33.3%
BEVERAGES - SOFT
5 companies
27.8%
BEVERAGES - ALCOH
3 companies
16.7%
CONSM PD - MISC DIS
1 company
5.6%
COSMETICS&TLTRS
1 company
5.6%
MED PRODUCTS
1 company
5.6%
FOOD - MISC/DIVERSIFIED
1 company
5.6%

Kevin Grundy's Ratings History at BNP Paribas Exane

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Keurig Dr Pepper, Inc stock logo
KDP
Keurig Dr Pepper
4/22/2026Upgrade$26.44$28.00Neutral
Keurig Dr Pepper, Inc stock logo
KDP
Keurig Dr Pepper
9/22/2025Downgrade$27.11Underperform
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
8/15/2025Reiterated Rating$155.08$177.00Outperform
CocaCola Company (The) stock logo
KO
CocaCola
7/21/2025Reiterated Rating$70.12$83.00Outperform